Skip to content

BioCryst Pharmaceuticals

US · BCRX #2766 by market cap Listed 1970
7.22 -0.10 -1.37%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
B
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
1 1
■ Upgrades■ Downgrades
  • 1 upgrade vs 1 downgrade among tracked analyst rating changes.
  • Most recent: RBC Capital moved from Buy to Hold on 2026-09-10.

Analyst consensus 6 analysts

Buy
Avg price target 17.00 +135.5%
Price target rangecurrent 7.22
Low11.00
Avg17.00
High30.00
Buy 67% Hold 33% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-05 Wedbush -- Buy 17.00
2026-11-04 RBC Capital -- Hold 11.00
2026-10-21 TD Cowen -- Buy 30.00
2026-10-09 BofA Securities -- Buy 15.00
2026-10-08 RBC Capital -- Hold 11.00
2026-09-30 J.P. Morgan -- Hold 13.00
2026-09-10 RBC Capital -- Hold 11.00
2026-09-08 Needham -- Buy 16.00
2026-08-06 Wedbush -- Buy 20.00
2026-08-06 H.C. Wainwright -- Buy 32.00
2026-08-05 TD Cowen -- Buy 30.00
2026-08-05 Needham -- Buy 16.00
2026-08-05 RBC Capital -- Buy 13.00
2026-07-15 BofA Securities -- Buy 15.00
2026-07-13 Wedbush -- Buy 21.00
2026-07-13 J.P. Morgan -- Hold 12.00
2026-07-07 RBC Capital -- Buy 14.00
2026-06-30 Cantor Fitzgerald -- Buy 29.00
2026-06-30 Wedbush -- Buy 21.00
2026-06-30 Needham -- Buy 16.00
2026-06-30 H.C. Wainwright -- Buy 32.00
2026-06-29 Needham -- Buy 16.00
2026-05-07 Wedbush -- Buy 21.00
2026-05-07 Citizens JMP -- Buy 28.00
2026-05-07 H.C. Wainwright -- Buy 32.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-09-10 RBC Capital Buy → Hold 11.00
2026-02-18 Evercore Hold → Buy 17.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-04 -- ±15.39% -3.85% (in line)
2026/Q2 2026-08-05 -- ±11.90% +0.55% (in line)
2026/Q1 2026-05-06 -- ±10.52% -2.21% (in line)
2025/Q4 2026-02-26 -- ±8.74% +4.64% (in line)
2025/Q3 2025-11-03 -- ±16.39% -6.28% (in line)
2025/Q2 2025-08-04 -- ±16.93% +9.81% (in line)
2025/Q1 2025-05-05 -- ±11.67% +23.52% (beat)
2024/Q4 2025-02-24 -- ±15.83% -9.99% (in line)
2024/Q3 2024-11-04 -- ±15.08% -12.81% (in line)
2024/Q2 2024-08-05 -- ±17.02% +6.98% (in line)
2024/Q1 2024-05-06 -- ±17.53% +18.43% (beat)
2023/Q4 2024-02-26 -- ±24.27% +1.40% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:40 · For reference only, not investment advice and not tailored to your situation.

BioCryst Pharmaceuticals discussion 0 comments

Add a comment